2016
DOI: 10.1016/j.bbrc.2016.04.028
|View full text |Cite
|
Sign up to set email alerts
|

Metabolites from invasive pests inhibit mitochondrial complex II: A potential strategy for the treatment of human ovarian carcinoma?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
3
3
1

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 31 publications
1
18
0
1
Order By: Relevance
“…ETC complex I, constitutes the entry point of electrons and is an essential site for ROS generation (33). Caulerpin has been reported to reduce respiratory complex II activity and to exhibit cytotoxicity to human dermal fibroblasts (14). In this study, caulerpin considerably reduced oxygen consumption rate and ATP level in both SW480 and LOVO cells, accompanied by an elevation in ROS.…”
Section: Discussionmentioning
confidence: 56%
See 3 more Smart Citations
“…ETC complex I, constitutes the entry point of electrons and is an essential site for ROS generation (33). Caulerpin has been reported to reduce respiratory complex II activity and to exhibit cytotoxicity to human dermal fibroblasts (14). In this study, caulerpin considerably reduced oxygen consumption rate and ATP level in both SW480 and LOVO cells, accompanied by an elevation in ROS.…”
Section: Discussionmentioning
confidence: 56%
“…In this study, caulerpin considerably reduced oxygen consumption rate and ATP level in both SW480 and LOVO cells, accompanied by an elevation in ROS. Mitochondria isolated from rat liver have been selected as a system in which mechanisms of bioenergetics are not altered (14). Therefore, liver mitochondrial and LOVO cells were used to explore the complex interactions between caulerpin and the organelle.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Caulerpin 53 overpowers the mitochondrial respiratory at complex II and increases ROS production in cisplatin-resistant C13 ovarian cancer cells, while it has no effect on the complexes I, III and IV [ 169 ], suggesting that some derivatives could be good candidates for the treatment of cisplatin-resistant cancer, once ovarian cancer cisplatin resistant cells are characterized by reduced oxygen consumption and increased dependence on glucose [ 170 ].…”
Section: Secondary Metabolites From Seaweeds With In Vitro Cytotoxmentioning
confidence: 99%